52-Week Low Club (December 28, 2007)
Some of these stocks hit 52-week lows and recovered off of lows so they won’t have a low close. But these did all touch or breach the 52-week lows. At the end…
Some of these stocks hit 52-week lows and recovered off of lows so they won’t have a low close. But these did all touch or breach the 52-week lows. At the end…
Davis Selected has bought 5.1% of MBIA (MBI). Just a few days ago, the fund put money into Merrill Lynch (MER). MBIA shares are rising on the news, up 11% to $22.29.…
For the December 14 period, short interest in financial stocks sky-rocketed compared to figures on November 30. Shares sold short in Citigroup (C) grew 20 million to 104.9 million. Shares short in…
Rite Aid Corporation (RAD) Ugly earnings. No turnaround here. Falls to $2.71 from 52-week high of $6.74. MBIA (MBI) Concerns about CDOs being insured here. Falls to $18.84 from 52-week high of…
It’s a big day for big caps to get eviscerated. Rite Aid (RAD) is off 20% after reporting a bad quarter/ MBIA (MBI) is down 18% on a negative outlook from S&P.…
We have been pretty critical of the ratings agencies not being on their toes and calling on things far too late. In fact, I have been an anti-fan of theirs all the…
Moody’s is having a look at the "AAA" rating carried by bond insurance firm MBIA (MBIA). MarketWatch writes that "Bond insurers agree to pay principal and interest when due in a timely…
MBIA Inc. (NYSE: MBI) has entered into a definitive agreement with global private equity firm Warburg Pincus to invest up to $1 billion in MBIA through a direct purchase of MBIA common…
According to Reuters, the former head of UnitedHealth gave up $400 million in stock options to settle chages with the SEC and the company. Reuters writes that the head of Rio Tinto…
According to Reuters, Nikon is seeing a sharp increase in demand from LCD makers. Reuters writes that the housing slump will last through 2009 and some home prices will drop 30%. Reuters…
MBIA (MBI) Downgrade by Moody’s. Falls to $25.84 from 52-week high of $76.02. Genentech (DNA) FDA rejects key drug. Drops to $65.54 from 52-week high of $89.73. AMD (AMD) More analyst concerns.…
If you think the "independent ratings agencies" are your friend and are out there looking out for your best interest, you have already been told time after time that they are not. …
According to Reuters, Goldman Sachs (GS) issued a report saying the housing sector had much further to fall and that some financial institutions would have to raise money to stay in business.…
We have already noted the Van der Moolen (NYSE:VDM) exit of all NYSE Specialist activities and we’ve already covered some of the other key stocks where Van der Moolen acts as a…
AMBAC (ABK) Bond insurance company dropping like a rock on fears that it has huge exposures to CDOs. Down to $21.62 from 52-week high of $96.10. Security Capital Assurance (SCA) Another bond…